Mocravimod

DB18151InvestigationalSmall molecule

Mocravimod: Overview.

Mechanism: Pharmacologically active on Sphingosine 1-phosphate receptor 1
Curator reviewed
Formula / weight: C₂₄H₂₆ClNO₃S · 443.99 g/mol (avg)
Also known as: 1,3-propanediol, 2-amino-2-(2-(2-chloro-4-((3-(phenylmethoxy)phenyl)thio)phenyl)ethyl)- · 2-amino-2-(2-(2-chloro-4-(3-benzyloxyphenylthio)phenyl)ethyl)-1,3-propanediol · Krp-203 free base

Resolves to

Compound

Structure

InChIKeyIINUNQPYJGJCJI-UHFFFAOYSA-NSMILESNC(CO)(CO)CCC1=CC=C(SC2=CC=CC(OCC3=CC=CC=C3)=C2)C=C1Cl

Targets

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mocravimod, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.